In summary, the antitumor pharmacological activity of CTS is mainly based on its role as a powerful immune stimulant compound, which effectively inhibits the growth of cancer cells and tumor development through the synergistic effect of the immune system (Figure 5). This evidence concerns the gene TTR and neoplasm.